Literature DB >> 23721997

Oral microflora and their relation to risk factors in HIV+ patients with oropharyngeal candidiasis.

A Sharifzadeh1, A R Khosravi, H Shokri, F Asadi Jamnani, M Hajiabdolbaghi, I Ashrafi Tamami.   

Abstract

OBJECTIVE: The purpose of this study was to determine the prevalence of oral microflora and association of oral candidiasis and multiple risk factors in HIV(+) patients. PATIENTS AND METHODS: The present study included 100 HIV-infected patients participated in Imam Khomeini Hospital, Tehran, Iran for Oropharyngeal candidiasis (OPC) and HIV. We assessed the presence or absence of OPC, and samples were obtained from the oral cavity and direct microscopic examination, gram staining and culture on standard microbiological media were performed in all patients. CD4(+) cell count/CD4(+) percentage were also calculated.
RESULTS: The demographic characteristics showed that the patients had a mean age of 32.3 years old, 78% male and 22% female. Patients belonging to 'O(+)' blood group (27%) were more prone to develop OPC. A total of 460 bacterial colonies were obtained and Streptococcus mutans (15.4%) was the most frequently isolated species in the HIV(+) patients, followed by Staphylococcus epidermidis (12.8%) and Corynebacterium (8.7%). In addition, 254 yeasts (from four different genera) were isolated from the patient under study. Candida species (94.4%) were the most frequently obtained genera, followed by Saccharomyces (2.4%), Kluyveromyces and Cryptococcus (1.6% for both) species. Candida albicans (37.2%) was the most common species isolated from HIV(+) patients with OPC and its frequency was significantly higher than that of other Candida species (P<0.05). Candida glabrata, C. dubliniensis, C. tropicalis, C. parapsilosis, C. krusei, C. lusitaniae, C. guilliermondii and C. norvegensis were also identified. Forty percent of the patients had angular cheilitis as the most frequent clinical variant. The mean CD4(+) cell counts were 154.5 cells/μL, with a range of 8 to 611 cells/μL. Thirty percent patients had a CD4(+) cell count between 101 and 200 cells/μL (28.7% of total yeasts isolated). Yeast and bacteria counts did not differ statistically among HIV(+) patients' subgroups with different levels of CD4(+) cells counts.
CONCLUSION: Our results showed that yeasts of the genus Candida were isolated at a comparable rate from the oral cavity of HIV(+) patients and there was no significant difference of the variables CD4(+) cell count and yeast counts. The findings of this study would be helpful in any further study, which, if done prospectively on a large cohort, can be confirmatory.
Copyright © 2013. Published by Elsevier SAS.

Entities:  

Mesh:

Year:  2013        PMID: 23721997     DOI: 10.1016/j.mycmed.2013.02.001

Source DB:  PubMed          Journal:  J Mycol Med        ISSN: 1156-5233            Impact factor:   2.391


  13 in total

1.  Diversity and antifungal resistance patterns of prevalent opportunistic pathogenic yeasts colonizing the oral cavities of asymptomatic human immunodeficiency virus-infected individuals, and their relation to CD4(+) counts.

Authors:  Deepa Anil Kumar; Sumathi Muralidhar; Uma Banerjee; Seemi Farhat Basir; Purva Mathur; Luqman Ahmad Khan
Journal:  Indian J Sex Transm Dis AIDS       Date:  2015 Jan-Jun

2.  Detection of ERG11 point mutations in Iranian fluconazole-resistant Candida albicans isolates.

Authors:  Ali Sardari; Hossein Zarrinfar; Rasoul Mohammadi
Journal:  Curr Med Mycol       Date:  2019-03

3.  Multicenter Comparison of Lung and Oral Microbiomes of HIV-infected and HIV-uninfected Individuals.

Authors:  James M Beck; Patrick D Schloss; Arvind Venkataraman; Homer Twigg; Kathleen A Jablonski; Frederic D Bushman; Thomas B Campbell; Emily S Charlson; Ronald G Collman; Kristina Crothers; Jeffrey L Curtis; Kimberly L Drews; Sonia C Flores; Andrew P Fontenot; Mary A Foulkes; Ian Frank; Elodie Ghedin; Laurence Huang; Susan V Lynch; Alison Morris; Brent E Palmer; Thomas M Schmidt; Erica Sodergren; George M Weinstock; Vincent B Young
Journal:  Am J Respir Crit Care Med       Date:  2015-12-01       Impact factor: 21.405

4.  Epidemiology of Oropharyngeal Candidiasis in Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome Patients and CD4+ Counts.

Authors:  Antoine Berberi; Ziad Noujeim; Georges Aoun
Journal:  J Int Oral Health       Date:  2015-03

Review 5.  Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species.

Authors:  Sarah G Whaley; Elizabeth L Berkow; Jeffrey M Rybak; Andrew T Nishimoto; Katherine S Barker; P David Rogers
Journal:  Front Microbiol       Date:  2017-01-12       Impact factor: 5.640

6.  Immune status, and not HIV infection or exposure, drives the development of the oral microbiota.

Authors:  M O Coker; E F Mongodin; S S El-Kamary; P Akhigbe; O Obuekwe; A Omoigberale; P Langenberg; C Enwonwu; L Hittle; W A Blattner; M Charurat
Journal:  Sci Rep       Date:  2020-07-02       Impact factor: 4.379

Review 7.  Oral mycobiome identification in atopic dermatitis, leukemia, and HIV patients - a systematic review.

Authors:  Camila Stofella Sodré; Paulo Matheus Guerra Rodrigues; Mayra Stambovsky Vieira; Alexandre Marques Paes da Silva; Lucio Souza Gonçalves; Marcia Gonçalves Ribeiro; Dennis de Carvalho Ferreira
Journal:  J Oral Microbiol       Date:  2020-08-17       Impact factor: 5.474

8.  Molecular analysis of fungal populations in patients with oral candidiasis using internal transcribed spacer region.

Authors:  Shinsuke Ieda; Masafumi Moriyama; Toru Takeshita; Toru Takashita; Takashi Maehara; Yumi Imabayashi; Shoichi Shinozaki; Akihiko Tanaka; Jun-Nosuke Hayashida; Sachiko Furukawa; Miho Ohta; Yoshihisa Yamashita; Seiji Nakamura
Journal:  PLoS One       Date:  2014-06-30       Impact factor: 3.240

Review 9.  Oropharyngeal Candidosis in HIV-Infected Patients-An Update.

Authors:  Shankargouda Patil; Barnali Majumdar; Sachin C Sarode; Gargi S Sarode; Kamran H Awan
Journal:  Front Microbiol       Date:  2018-05-15       Impact factor: 5.640

10.  Genetic diversity and antifungal susceptibility of Candida albicans isolates from Iranian HIV-infected patients with oral candidiasis.

Authors:  Iradj Ashrafi Tamai; Babak Pakbin; Bahar Nayeri Fasaei
Journal:  BMC Res Notes       Date:  2021-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.